Cantuzumab mertansine | Interleukin Related interleukin-related.com

Product Name :
Cantuzumab mertansine

Search keywords :
Cantuzumab mertansine

drugId :
null

Target Vo:
Mucin-1

Target Vo Short Name :
MUC1

Moa_Name:
Apoptosis stimulants

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Immunogen Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Neoplasms

Termination Status :
Phase 1 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-SHP2 (Tyr542) Antibody
TWIST Antibody
Lysozyme Antibody: Lysozyme Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 17 kDa, targeting to Lysozyme. It can be used for WB,IHC-P assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts